SGTX - Sigilon Therapeutics GAAP EPS of -$0.43 revenue of $3.17M May, 12 2022 05:02 PM Sigilon Therapeutics Inc. Sigilon Therapeutics press release (NASDAQ:SGTX): Q1 GAAP EPS of -$0.43. Collaboration revenue of $3.17M. For further details see: Sigilon Therapeutics GAAP EPS of -$0.43, revenue of $3.17M